The impact of metastasectomy on survival of patients with synchronous metastatic renal cell cancer in Finland: A nationwide study.
Lauri LaruHanna RonkainenPasi OhtonenMarkku H VaaralaPublished in: Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society (2024)
Complete metastasectomy, when possible, can be considered as a treatment option for selected patients with synchronous mRCC who are fit for surgery. By contrast, we found no survival benefit from an incomplete metastasectomy suggesting that such procedures should not be performed for these patients.